Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring.

advanced biotechnology bioassay development digital cell biology drug discovery nanoscale cell culture optical manipulation techniques single cell technology

Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
09 2019
Historique:
received: 31 01 2019
revised: 16 05 2019
accepted: 16 05 2019
pubmed: 22 5 2019
medline: 30 7 2020
entrez: 22 5 2019
Statut: ppublish

Résumé

The new and rapid advancement in the complexity of biologics drug discovery has been driven by a deeper understanding of biological systems combined with innovative new therapeutic modalities, paving the way to breakthrough therapies for previously intractable diseases. These exciting times in biomedical innovation require the development of novel technologies to facilitate the sophisticated, multifaceted, high-paced workflows necessary to support modern large molecule drug discovery. A high-level aspiration is a true integration of "lab-on-a-chip" methods that vastly miniaturize cellulmical experiments could transform the speed, cost, and success of multiple workstreams in biologics development. Several microscale bioprocess technologies have been established that incrementally address these needs, yet each is inflexibly designed for a very specific process thus limiting an integrated holistic application. A more fully integrated nanoscale approach that incorporates manipulation, culture, analytics, and traceable digital record keeping of thousands of single cells in a relevant nanoenvironment would be a transformative technology capable of keeping pace with today's rapid and complex drug discovery demands. The recent advent of optical manipulation of cells using light-induced electrokinetics with micro- and nanoscale cell culture is poised to revolutionize both fundamental and applied biological research. In this review, we summarize the current state of the art for optical manipulation techniques and discuss emerging biological applications of this technology. In particular, we focus on promising prospects for drug discovery workflows, including antibody discovery, bioassay development, antibody engineering, and cell line development, which are enabled by the automation and industrialization of an integrated optoelectronic single-cell manipulation and culture platform. Continued development of such platforms will be well positioned to overcome many of the challenges currently associated with fragmented, low-throughput bioprocess workflows in biopharma and life science research.

Identifiants

pubmed: 31112285
doi: 10.1002/bit.27024
pmc: PMC6771990
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2393-2411

Informations de copyright

© 2019 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.

Références

Nano Lett. 2013 Jun 12;13(6):2766-70
pubmed: 23659726
Commun Biol. 2018 May 3;1:41
pubmed: 30271925
Nat Med. 2009 Sep;15(9):1088-92
pubmed: 19684583
Lab Chip. 2009 Jun 21;9(12):1732-9
pubmed: 19495457
Nature. 2003 Aug 14;424(6950):810-6
pubmed: 12917694
Opt Express. 2005 Jul 25;13(15):5831-45
pubmed: 19498588
Int Immunol. 2014 Dec;26(12):649-57
pubmed: 25135889
Nano Lett. 2011 Sep 14;11(9):3763-7
pubmed: 21838243
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17902-7
pubmed: 19004776
J Biotechnol. 2014 Jun 20;180:10-6
pubmed: 24704608
Nature. 1975 Aug 7;256(5517):495-7
pubmed: 1172191
Biotechnol Bioeng. 2019 Sep;116(9):2393-2411
pubmed: 31112285
Nanoscale. 2009 Oct;1(1):133-7
pubmed: 20644872
Nat Biotechnol. 2006 Jun;24(6):703-7
pubmed: 16699501
Methods Mol Biol. 2018;1827:211-233
pubmed: 30196500
Biotechnol J. 2019 Apr;14(4):e1800466
pubmed: 30350923
Lab Chip. 2017 Dec 19;18(1):106-114
pubmed: 29211085
Anal Chem. 2005 Sep 15;77(18):6004-11
pubmed: 16159134
Protein Eng Des Sel. 2013 Oct;26(10):663-70
pubmed: 24046438
J Immunol Methods. 2004 Jul;290(1-2):69-80
pubmed: 15261572
Nat Med. 2010 Jan;16(1):123-8
pubmed: 20023635
Cell Cycle. 2019 Apr;18(8):784-794
pubmed: 30907235
Nature. 2008 May 29;453(7195):667-71
pubmed: 18449194
Small. 2014 Aug 13;10(15):3026-31
pubmed: 24719234
Lab Chip. 2009 Jun 21;9(12):1714-20
pubmed: 19495455
J Biosci Bioeng. 2018 Apr;125(4):464-469
pubmed: 29174537
Nucleic Acids Res. 2002 Jan 15;30(2):E9
pubmed: 11788735
Angew Chem Int Ed Engl. 2014 Jan 13;53(3):842-6
pubmed: 24402800
Opt Express. 2009 Apr 13;17(8):6209-17
pubmed: 19365444
Biotechnol J. 2017 Jun;12(6):
pubmed: 28371300
Sci Rep. 2016 Mar 04;6:22630
pubmed: 26940301
Biotechnol Adv. 2015 Dec;33(8):1878-96
pubmed: 26523782
Biotechnol Prog. 2015 Jan-Feb;31(1):258-67
pubmed: 25395220
J Biol Chem. 2016 Nov 25;291(48):25106-25119
pubmed: 27694443
Nat Photonics. 2008;2(2):86-89
pubmed: 19789729
Drug Metab Pharmacokinet. 2019 Feb;34(1):25-41
pubmed: 30472066
Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30
pubmed: 22159888
Microscopy (Oxf). 2016 Aug;65(4):341-52
pubmed: 27107009
MAbs. 2012 Nov-Dec;4(6):753-60
pubmed: 23778268
Biotechnol Prog. 2015 Jan-Feb;31(1):239-47
pubmed: 25403790
Nat Biotechnol. 2004 Nov;22(11):1393-8
pubmed: 15529164
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:18-28
pubmed: 30423523
Adv Exp Med Biol. 2018;1068:89-102
pubmed: 29943298
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11399-404
pubmed: 21697512
Nature. 2005 Jul 21;436(7049):370-2
pubmed: 16034413
J Immunol Methods. 2018 Apr;455:88-94
pubmed: 29357282
Lab Chip. 2010 Jan 21;10(2):165-72
pubmed: 20066243
Nat Methods. 2008 Jun;5(6):491-505
pubmed: 18511917
Nat Struct Mol Biol. 2018 Mar;25(3):289-296
pubmed: 29434346
J Chromatogr A. 2014 May 30;1344:23-30
pubmed: 24768125
Biotechnol Prog. 2007 Mar-Apr;23(2):465-72
pubmed: 17261021
Hybrid Hybridomics. 2003 Oct;22(5):329-31
pubmed: 14678651
Methods Mol Biol. 2015;1319:155-75
pubmed: 26060074
RSC Adv. 2019 Feb 8;9(9):4963-4981
pubmed: 35514668
Opt Express. 2018 Mar 5;26(5):5300-5309
pubmed: 29529735
MAbs. 2015;7(1):138-51
pubmed: 25523975
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7843-8
pubmed: 8755564
Methods. 2017 Mar 1;116:34-42
pubmed: 27864085
MAbs. 2016 Aug-Sep;8(6):1035-44
pubmed: 27224530
J Immunol. 2009 Sep 1;183(5):3177-87
pubmed: 19675172
Lab Chip. 2010 Jul 7;10(13):1655-61
pubmed: 20448870
Nat Med. 2004 Aug;10(8):871-5
pubmed: 15247913
MAbs. 2018 Oct;10(7):1073-1083
pubmed: 30130444
Mol Aspects Med. 2018 Feb;59:47-61
pubmed: 28927942
Opt Express. 2014 Jan 27;22(2):1372-80
pubmed: 24515144
PLoS One. 2014 Jan 27;9(1):e87099
pubmed: 24475232
Rev Sci Instrum. 2004 Sep;75(9):2787-809
pubmed: 16878180
Biotechnol Prog. 2018 Nov;34(6):1438-1446
pubmed: 30009534
J Phys Chem Lett. 2014 Sep 4;5(17):2957-67
pubmed: 26278243
Prostate. 2018 Sep;78(13):981-991
pubmed: 29790189
J Pharm Sci. 2015 Jun;104(6):1885-1898
pubmed: 25821140
Annu Rev Biochem. 2008;77:205-28
pubmed: 18307407
Anal Chem. 2018 Feb 6;90(3):2224-2229
pubmed: 29290124
Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):640-56
pubmed: 16904789
Opt Express. 2009 Mar 30;17(7):5232-9
pubmed: 19333286
Lab Chip. 2011 Apr 7;11(7):1292-7
pubmed: 21311817
Opt Lett. 2012 Sep 15;37(18):3744-6
pubmed: 23041845
Biotechnol Prog. 2018 May;34(3):613-623
pubmed: 29882350
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13035-40
pubmed: 21788476
Nat Biotechnol. 2013 Feb;31(2):166-9
pubmed: 23334449
MAbs. 2013 Sep-Oct;5(5):787-94
pubmed: 23883920
Appl Microbiol Biotechnol. 2018 Apr;102(7):3363-3374
pubmed: 29484477
Nature. 2014 Mar 13;507(7491):181-9
pubmed: 24622198
MAbs. 2015;7(3):505-15
pubmed: 25759214
Curr Opin Struct Biol. 2016 Jun;38:163-73
pubmed: 27525816
Small. 2018 Nov;14(45):e1803342
pubmed: 30307718
Nat Biotechnol. 2010 Sep;28(9):965-9
pubmed: 20802495
Opt Lett. 1986 May 1;11(5):288
pubmed: 19730608
Nat Photonics. 2011 May 31;5:318-321
pubmed: 22145010
Front Immunol. 2017 Sep 04;8:986
pubmed: 28928732
Biophys J. 1992 Feb;61(2):569-82
pubmed: 19431818
J Chromatogr A. 2015 Dec 11;1424:51-8
pubmed: 26596873
MAbs. 2014 Mar-Apr;6(2):327-39
pubmed: 24441081
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
Adv Biochem Eng Biotechnol. 2014;139:11-33
pubmed: 24196317
Lab Chip. 2010 Dec 7;10(23):3213-7
pubmed: 20835428

Auteurs

Marsela Jorgolli (M)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Tanner Nevill (T)

Product Applications, Berkeley Lights, Inc, Emeryville, California.

Aaron Winters (A)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Irwin Chen (I)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Su Chong (S)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Fen-Fen Lin (FF)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Marissa Mock (M)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Ching Chen (C)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Kim Le (K)

Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California.

Christopher Tan (C)

Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California.

Philip Jess (P)

Product Applications, Berkeley Lights, Inc, Emeryville, California.

Han Xu (H)

Drug Discovery, A2 Biotherapeutics, Westlake Village, California.

Agi Hamburger (A)

Drug Discovery, A2 Biotherapeutics, Westlake Village, California.

Jennitte Stevens (J)

Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California.

Trent Munro (T)

Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California.

Ming Wu (M)

Department of Electrical Engineering and Computer Sciences, University of California at Berkeley, Berkeley, California.

Philip Tagari (P)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Les P Miranda (LP)

Amgen Research, One Amgen Center Drive, Thousand Oaks, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH